Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer

NCT02676986 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

221

Enrollment

OTHER

Sponsor class

Conditions

Primary Breast Cancer ER+ve
Primary Breast Cancer AR+ve TNBN

Interventions

DRUG: Enzalutamide
DRUG: Exemestane

Sponsor

Queen Mary University of London

Collaborators

[object Object]